Evidence map›Paper›PMID 36127477›Full record

ReviewNature reviews. Immunology2023

Three-dimensional genome organization in immune cell fate and function.

Sergi Cuartero, Grégoire Stik, Ralph Stadhouders

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Regulation of immune signal integration and memory by inflammation-induced chromosome conformation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Exhausted CD8Nature immunology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Biomolecular condensates in immune cell fate.Nature reviews. Immunology · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Sergi Cuartero *Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain. scuartero@carrerasresearch.org.ORCID http://orcid.org/0000-0002-9338-583X
Grégoire Stik *Centre for Genomic Regulation (CRG), Institute of Science and Technology (BIST), Barcelona, Spain. gregoire.stik@crg.eu.ORCID http://orcid.org/0000-0002-1404-1992
Ralph Stadhouders *Department of Pulmonary Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. r.stadhouders@erasmusmc.nl.ORCID http://orcid.org/0000-0002-1060-5607
Erasmus MC · NLJosep Carreras Leukaemia Research Institute · ESUniversitat Pompeu Fabra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune cell development and activation demand the precise and coordinated control of transcriptional programmes. Three-dimensional (3D) organization of the genome has emerged as an important regulator of chromatin state, transcriptional activity and cell identity by facilitating or impeding long-range genomic interactions among regulatory elements and genes. Chromatin folding thus enables cell type-specific and stimulus-specific transcriptional responses to extracellular signals, which are essential for the control of immune cell fate, for inflammatory responses and for generating a diverse repertoire of antigen receptor specificities. Here, we review recent findings connecting 3D genome organization to the control of immune cell differentiation and function, and discuss how alterations in genome folding may lead to immune dysfunction and malignancy.

Indexed as

ChromatinChromosomesCell DifferentiationGenomeHumansChromatin

Identifiers

PMID36127477
OpenAlexW4296488518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.